Skip to content

Associations Between Diabetes, Arterial Stiffness and Fibulin-1 in Patients Undergoing Heart- and Vascular Surgery?

Is There an Association Between the Presence of Diabetes, the Degree of Arterial Stiffness and a New Plasma Marker for Vascular Elasticity, Fibulin-1 in Patients Undergoing Heart- and Vascular Surgery?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01106573
Enrollment
1400
Registered
2010-04-20
Start date
2010-06-30
Completion date
2013-05-31
Last updated
2010-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Abdominal, Arteriosclerosis, Carotid Stenosis, Coronary Artery Disease, Thrombosis

Keywords

Diabetes Mellitus, Arteriosclerosis, Intima media thickness, arterial stiffness, pulsewave velocity, fibulin-1

Brief summary

Diabetes Mellitus (DM) is frequently appearing in patients with cardiovascular disease and these patients, as a consequence herby, has a lesser prognosis. DM is often related to increased arterial stiffness and hypertension. The investigators thesis is that DM and pre-diabetes is prevalent in patients undergoing cardiovascular surgery and to some extend is under-diagnosed. At the same time the investigators imagine that DM is closely related to the degree of arterial stiffness, and that these parameters are closely related to a new biochemical marker, fibulin-1. The investigators aim to describe the prevalence of type 2 DM and dysmetabolism in patients admitted to the hospital to undergo cardiovascular surgery and besides that to investigate if there is a connection between the degree of the dysmetabolism and arterial disease, by studying arterial stiffness and by measuring a new biochemical marker, fibulin-1, which the investigators newly have identified. The results of this project will give us a measure for the quantity of unknown DM in patients undergoing cardiovascular surgery and furthermore tell us more in terms of the connections between a newly identified plasma arterial marker, arterial stiffness and diabetes.

Interventions

None listed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years of age * undergoing heart- or vascular surgery

Exclusion criteria

* Physical or mental disability not enabling participation in the study

Countries

Denmark

Contacts

Primary ContactMaria Lyck Hansen, Ph.d student
maria.lyck.hansen@ouh.regionsyddanmark.dk004540828020
Backup ContactLars Melholt Rasmussen, Professor, MD
lars.melholt.rasmussen@ouh.regionsyddanmark.dk0045-6541 4506

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026